Keryx Biopharmaceuticals, Inc. – NASDAQ:KERX
Keryx Biopharmaceuticals stock price today
Keryx Biopharmaceuticals stock price monthly change
Keryx Biopharmaceuticals stock price quarterly change
Keryx Biopharmaceuticals stock price yearly change
Keryx Biopharmaceuticals key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.76 |
Revenue | 94.21M |
EBITDA | -89.03M |
Income | -90.72M |
Revenue Q/Q | 86.95% |
Revenue Y/Y | 82.97% |
Profit margin | -96.41% |
Oper. margin | -94.04% |
Gross margin | 62.49% |
EBIT margin | -94.04% |
EBITDA margin | -94.5% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeKeryx Biopharmaceuticals stock price history
Keryx Biopharmaceuticals stock forecast
Keryx Biopharmaceuticals financial statements
| Dec 2017 | 18.68M | -30.42M | -162.88% |
|---|---|---|---|
| Mar 2018 | 21.75M | -21.89M | -100.67% |
| Jun 2018 | 25.74M | -21.29M | -82.7% |
| Sep 2018 | 28.03M | -17.10M | -61.03% |
| Dec 2017 | 158872000 | 172.96M | 108.87% |
|---|---|---|---|
| Mar 2018 | 140122000 | 171.73M | 122.56% |
| Jun 2018 | 145651000 | 186.84M | 128.28% |
| Sep 2018 | 151784000 | 206.00M | 135.72% |
| Dec 2017 | -20.17M | -81K | -216K |
|---|---|---|---|
| Mar 2018 | -33.43M | -78K | 69K |
| Jun 2018 | -21.36M | 26K | 10.70M |
| Sep 2018 | -23.38M | 0 | 15.07M |
Keryx Biopharmaceuticals other data
| Patent |
|---|
Application Filling date: 5 Jun 2020 Issue date: 24 Sep 2020 |
Application Filling date: 5 Apr 2019 Issue date: 9 Jul 2020 |
Application USE OF FERRIC CITRATE IN THE TREATMENT OF AND THE REDUCTION OF MORTALITY AND MORBIDITY RELATED TO ADVERSE CARDIAC EVENTS IN CHRONIC KIDNEY DISEASE PATIENTS Filling date: 11 Dec 2018 Issue date: 10 Oct 2019 |
Application Filling date: 8 Oct 2018 Issue date: 5 Sep 2019 |
-
What's the price of Keryx Biopharmaceuticals stock today?
One share of Keryx Biopharmaceuticals stock can currently be purchased for approximately $3.35.
-
When is Keryx Biopharmaceuticals's next earnings date?
Unfortunately, Keryx Biopharmaceuticals's (KERX) next earnings date is currently unknown.
-
Does Keryx Biopharmaceuticals pay dividends?
No, Keryx Biopharmaceuticals does not pay dividends.
-
What is Keryx Biopharmaceuticals's stock symbol?
Keryx Biopharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "KERX".
-
How do i buy shares of Keryx Biopharmaceuticals?
Shares of Keryx Biopharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Keryx Biopharmaceuticals went public?
Keryx Biopharmaceuticals, Inc. is publicly traded company for more then 25 years since IPO on 28 Jul 2000.